substance p has been researched along with Sclerosis, Systemic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (55.56) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertinotti, L; Casale, R; Colangelo, N; Del Rosso, A; Matucci-Cerinic, M; Pietrini, U; Zoppi, M | 1 |
| Bény, JL; Marie, I | 1 |
| Bertinotti, L; Casale, R; Cozzi, F; Del Rosso, A; Fanciullacci, M; Generini, S; Giacomelli, R; Matucci-Cerinic, M; Messori, A; Pietrini, U; Pignone, A; Sicuteri, R | 1 |
| Brodecka, H; Glinska-Ferenz, M; Glinski, W; Kowalski, D | 1 |
| Haustein, UF; Seikowski, K; Weber, B | 1 |
| Akesson, A; Scheja, A; Sundler, F; Wallengren, J | 1 |
| Cailes, J; du Bois, RM; Evans, TW; Winter, S | 1 |
| Freedman, RR; Girgis, R; Mayes, MD | 1 |
| Glinska-Ferenz, M; Glinski, W; Pierozynska-Dubowska, M | 1 |
1 review(s) available for substance p and Sclerosis, Systemic
| Article | Year |
|---|---|
The use of pupillometry in joint and connective tissue diseases.
Topics: Autoimmune Diseases; Connective Tissue Diseases; Diagnostic Techniques, Ophthalmological; Dry Eye Syndromes; Humans; Joint Diseases; Neurotransmitter Agents; Parasympathetic Nervous System; Pupil Disorders; Reflex, Pupillary; Rheumatic Diseases; Scleroderma, Systemic; Sjogren's Syndrome; Substance P; Sympathetic Nervous System | 2002 |
2 trial(s) available for substance p and Sclerosis, Systemic
| Article | Year |
|---|---|
Pupillocynetic activity of substance P in systemic sclerosis.
Topics: Aged; Autoantibodies; Female; Humans; Iris; Male; Middle Aged; Neurons, Afferent; Pupil; Reflex, Pupillary; Scleroderma, Systemic; Substance P | 2003 |
Defective endothelially mediated pulmonary vasodilation in systemic sclerosis.
Topics: Adenosine; Adult; Capillaries; Cardiac Output; Echocardiography, Doppler; Endothelium, Vascular; Female; Humans; Hypertension, Pulmonary; Infusions, Intravenous; Lung; Male; Microcirculation; Middle Aged; Prospective Studies; Pulmonary Circulation; Scleroderma, Systemic; Stroke Volume; Substance P; Vascular Resistance; Vasodilation; Vasodilator Agents | 1998 |
6 other study(ies) available for substance p and Sclerosis, Systemic
| Article | Year |
|---|---|
Endothelial dysfunction in murine model of systemic sclerosis: tight-skin mice 1.
Topics: Acetylcholine; Adenosine Triphosphate; Animals; Aorta, Thoracic; Bradykinin; Calcium; Disease Models, Animal; Endothelium, Vascular; Iloprost; In Vitro Techniques; Isometric Contraction; Mice; Mice, Inbred C57BL; Mice, Mutant Strains; Microscopy, Confocal; Nitric Oxide; Nitric Oxide Synthase; Scleroderma, Systemic; Skin; Substance P; Vasodilation; Vasodilator Agents | 2002 |
Neuropeptides in psoriasis: possible role of beta-endorphin in the pathomechanism of the disease.
Topics: beta-Endorphin; Capsaicin; Dermatitis, Atopic; Humans; Neuropeptides; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1994 |
[Substance P and vasoactive intestinal peptide in patients with progressive scleroderma. Determination of plasma level before and after autogenic training].
Topics: Adolescent; Adult; Aged; Arousal; Autogenic Training; Female; Fingers; Humans; Male; Middle Aged; Raynaud Disease; Reference Values; Regional Blood Flow; Scleroderma, Systemic; Substance P; Vasoactive Intestinal Peptide | 1995 |
Occurrence and distribution of peptidergic nerve fibers in skin biopsies from patients with systemic sclerosis.
Topics: Adult; Aged; Aged, 80 and over; Biopsy, Needle; Calcitonin Gene-Related Peptide; Case-Control Studies; Female; Humans; Immunohistochemistry; Male; Middle Aged; Nerve Fibers; Neuropeptide Y; Neuropeptides; Scleroderma, Systemic; Skin; Substance P; Vasoactive Intestinal Peptide | 1996 |
Abnormal responses to endothelial agonists in Raynaud's phenomenon and scleroderma.
Topics: Blood Flow Velocity; Bradykinin; Dose-Response Relationship, Drug; Endothelium, Vascular; Female; Fingers; Humans; Male; Methacholine Chloride; Muscarinic Agonists; Nitroprusside; Raynaud Disease; Scleroderma, Systemic; Substance P; Vasodilator Agents | 2001 |
Neurogenic inflammation induced by capsaicin in patients with psoriasis.
Topics: Administration, Cutaneous; Adult; Age Factors; Capsaicin; Dose-Response Relationship, Drug; Erythema; Forearm; Humans; Inflammation; Psoriasis; Scleroderma, Systemic; Skin; Substance P | 1991 |